
United States · research
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
PrivateFor profit
Set against 1,463 research companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 5% of those with a founding year; website ranked #11,863,577 in the world, about 143 visits a month.
BiotechnologyHealth CareLife ScienceMedical
One of 1,463 research companies in United States, and of 3,254 in the industry worldwide.
What the source datasets report. We have not watched these rounds ourselves.
$19M
raised in total, currency not stated across 3 rounds
Last raised Jul 2024, 2 years ago
Who started it and how it trades.
Everything the source datasets list about Rejuvenate Bio, field by field. Contact details are held but never shown.
The company7 fields
Where3 fields
Size and reach3 fields
Funding, as listed7 fields
About this record2 fields
Growth, as the source summarises it
Rejuvenate Bio announced that its gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes, as published in the Journal Cellular Reprogramming. Additionally, Rejuvenate Bio received a $4 million grant to develop gene therapy with longevity potential.
1,463 research companies in United States, filtered by size, age and reach, ready to export with emails on Pro.